GlassScriptPhysician profile
Elizabeth Blair
NPI 1538201553
$3,499.13
in general payments reported to CMS, 2019-2025
33 companies · $475 in 2025
The $475 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $503 · 2020: $297 · 2021: $325 · 2022: $625 · 2023: $736 · 2024: $538 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,748.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $486.02 | 2019-2025 | |
| Astellas Pharma US INC | $338.12 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $309.22 | 2019-2023 | Liletta, Orilissa, Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $251.18 | 2019-2025 | Aptima, Acessa Provu System |
| Shield Therapeutics INC | $223.61 | 2023-2025 | Accrufer |
| Sage Therapeutics, LLC | $168.75 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $135.46 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $127.51 | 2022-2025 | |
| Organon LLC | $124.21 | 2023-2025 | Nexplanon, Nuvaring, Jada System |
| Exact Sciences Corporation | $121.65 | 2023-2025 | Cologuard Collection Kit |
| Millicent US INC | $113.38 | 2023-2025 | Intrarosa, Femlyv |
| Myriad Women'S Health, INC. | $109.38 | 2023 | Myrisk |
| Evofem Biosciences, INC. | $99.24 | 2022-2023 | Phexxi |
| Amgen INC. | $94.62 | 2019-2021 | |
| Exeltis, USA INC. | $93.10 | 2022-2025 | Slynd |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $88.44 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $78.57 | 2019-2022 | |
| Agile Therapeutics, INC. | $57.79 | 2021-2023 | Twirla |
| Sumitomo Pharma America, INC. | $50.86 | 2023 | Myfembree |
| Myovant Sciences INC. | $50.11 | 2022 | |
| Sanofi Pasteur INC. | $45.96 | 2023-2025 | |
| Minerva Surgical, INC | $41.45 | 2019-2024 | |
| Avion Pharmaceuticals | $38.87 | 2023 | Balcoltra |
| Mission Pharmacal Company | $35.11 | 2019-2020 | |
| Scynexis, INC. | $33.84 | 2022 | |
| Ethicon US, LLC | $31.70 | 2021-2025 | Enseal, Harmonic |
| Coopersurgical, INC. | $29.27 | 2020 | |
| Siemens Medical Solutions USA, INC. | $28.05 | 2022 | |
| Amag Pharmaceuticals, INC. | $24.56 | 2019 | |
| Daiichi Sankyo INC. | $23.72 | 2022 | |
| Supernus Pharmaceuticals, INC. | $19.61 | 2025 | Qelbree |
| Currax Pharmaceuticals LLC | $13.72 | 2022 | |
| Lilly USA, LLC | $12.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Blair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.